Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif

Nature Communications

Volumn 4, Issue , 2013, Pages

  Hamilton, Mark P ^a   Rajapakshe, Kimal ^a   Hartig, Sean M ^a   Reva, Boris ^b   McLellan, Michael D ^c   Kandoth, Cyriac ^c   Ding, Li ^c,d,e   Zack, Travis I ^f   Gunaratne, Preethi H ^a,g   Wheeler, David A ^a   Coarfa, Cristian ^a   McGuire, Sean E ^a,h  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e USA   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g University of Houston   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 130; MICRORNA 17; MICRORNA 18; MICRORNA 19; MICRORNA 210; MICRORNA 455; MICRORNA 93; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CANCER; ENZYME ACTIVITY; GENETIC ENGINEERING; IDENTIFICATION METHOD; MUTATION; RNA; TUMOR;

ARTICLE; CANCER GENETICS; CANCER INHIBITION; CANCER TISSUE; CONTROLLED STUDY; EXOME; GENE MUTATION; GENE SEQUENCE; HUMAN; ONCOGENE; RNA ANALYSIS; RNA BINDING; SIGNAL TRANSDUCTION;

3' UNTRANSLATED REGIONS; ALGORITHMS; AMINO ACID MOTIFS; CARCINOGENESIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MICRORNAS; MULTIGENE FAMILY; MUTATION; NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84887641104     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3730     Document Type: Article

References (53)

1. Selbach, M. et al. Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63 (2008).
2. Mukherji, S. et al. MicroRNAs can generate thresholds in target gene expression. Nat. Genet. 43, 854-859 (2011).
3. Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840 (2010).
4. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005). (Pubitemid 40839735)
5. Martello, G. et al. A microRNA targeting dicer for metastasis control. Cell 141, 1195-1207 (2010).
6. Kumar, M. S., Lu, J., Mercer, K. L., Golub, T. R. & Jacks, T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 39, 673-677 (2007). (Pubitemid 46676103)
7. Volinia, S. et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 20, 589-599 (2010).
8. Darido, C. et al. Targeting of the tumor suppressor GRHL3 by a miR-21- dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer Cell 20, 635-648 (2011).
9. Olive, V. et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 23, 2839-2849 (2009).
10. Conkrite, K. et al. miR-17B92 cooperates with RB pathway mutations to promote retinoblastoma. Genes Dev. 25, 1734-1745 (2011).
11. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
12. Wang, Y. et al. Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex. Nature 456, 921-926 (2008).
13. Friedman, R. C., Farh, K. K., Burge, C. B. & Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105 (2009).
14. Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005). (Pubitemid 40094598)
15. Grimson, A. et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105 (2007). (Pubitemid 46991392)
16. Chi, S. W., Zang, J. B., Mele, A. & Darnell, R. B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460, 479-486 (2009).
17. Hafner, M. et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141, 129-141 (2010).
18. Hafner, M., Lianoglou, S., Tuschl, T. & Betel, D. Genome-wide identification of miRNA targets by PAR-CLIP. Methods 58, 94-105 (2012).
19. The Cancer Genome Atlas Research Network. The Cancer Genome Atlas Pan- Cancer analysis project. Nat Genet. 45, 1113-1120 (2013).
20. Skalsky, R. L. et al. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog. 8, e1002484 (2012).
21. Lipchina, I. et al. Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. Genes Dev. 25, 2173-2186 (2011).
22. Gottwein, E. et al. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10, 515-526 (2011).
23. Kishore, S. et al. A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nat. Methods 8, 559-564 (2011).
24. Haecker, I. et al. Ago HITS-CLIP expands understanding of Kaposi's sarcomaassociated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog. 8, e1002884 (2012).
25. Helwak, A., Kudla, G., Dudnakova, T. & Tollervey, D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153, 654-665 (2013).
26. O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V. & Mendell, J. T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839-843 (2005). (Pubitemid 40839736)
27. Dees, N. D. et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 22, 1589-1598 (2012).
28. Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333-339 (2013).
29. Reva, B., Antipin, Y. & Sander, C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).
30. Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).
31. Zack, T. I. et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45, 1134-1140 (2013).
32. Hong, L. et al. The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res. 70, 8547-8557 (2010).
33. Song, M. S., Salmena, L. & Pandolfi, P. P. The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283-296 (2012).
34. Massague, J. TGFbeta in cancer. Cell 134, 215-230 (2008).
35. Weber, A. et al. Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation. EMBO J. 27, 1563-1574 (2008). (Pubitemid 351794031)
36. Li, L., Shi, J. Y., Zhu, G. Q. & Shi, B. MiR-17-92 cluster regulates cell proliferation and collagen synthesis by targeting TGFB pathway in mouse palatal mesenchymal cells. J. Cell. Biochem. 113, 1235-1244 (2012).
37. Mestdagh, P. et al. The miR-17-92 microRNA cluster regulates multiple components of the TGF-beta pathway in neuroblastoma. Mol. Cell 40, 762-773 (2010).
38. Kim, K. et al. Identification of oncogenic microRNA-17-92/ZBTB4/ specificity protein axis in breast cancer. Oncogene 31, 1034-1044 (2012).
39. Banerji, S. et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486, 405-409 (2012).
40. Doench, J. G. & Sharp, P. A. Specificity of microRNA target selection in translational repression. Genes Dev. 18, 504-511 (2004). (Pubitemid 38372808)
41. Solomon, E., Li, H., Duhachek Muggy, S., Syta, E. & Zolkiewska, A. The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12. J. Biol. Chem. 285, 21969-21977 (2010).
42. Tecalco-Cruz, A. C. et al. Transforming growth factor-beta/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNONSMAD4. J. Biol. Chem. 287, 26764-26776 (2012).
43. Bonnie, S. et al. TGF-b induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat. Cell Biol. 3, 587-595 (2001).
44. Krek, A. et al. Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500 (2005). (Pubitemid 40617277)
45. Betel, D., Wilson, M., Gabow, A., Marks, D. S. & Sander, C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 36, D149-D153 (2008). (Pubitemid 351149712)
46. Ebert, M. S., Neilson, J. R. & Sharp, P. A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721-726 (2007). (Pubitemid 47338166)
47. Corcoran, D. L. et al. PARalyzer: definition of RNA binding sites from PARCLIP short-read sequence data. Genome Biol. 12, R79 (2011).
48. Loeb, G. B. et al. Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol. Cell 48, 760-770 (2012).
49. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).
50. Bullard, J. H., Purdom, E., Hansen, K. D. & Dudoit, S. Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments. BMC Bioinformatics 11, 94 (2010).
51. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 (2010).
52. Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).
53. Burkhart, D. L. et al. Regulation of RB transcription in vivo by RB family members. Mol. Cell Biol. 30, 1729-1745 (2010).